HCA Healthcare (HCA) and UnitedHealth (UNH) on Torvanta's measures: HCA grades higher on 3 of the 4 factor families and UNH on 1.
| HCA | UNH | |
|---|---|---|
| Value grade | B+ | B- |
| Growth grade | C | D+ |
| Profitability grade | n/a | C+ |
| Momentum grade | C | C- |
| Market value | n/a | $360.3B |
| P/E (trailing) | n/a | 25.8x |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $76.4B | $450.1B |
| Revenue growth (y/y) | n/a | +6% |
| Operating margin | 15.7% | 4.8% |
| Return on invested capital | n/a | 12.4% |
| Free-cash-flow yield | 8.3% | 6.6% |
| Total return, 1 year | +10.1% | +15.5% |
| Total return, 3 years | +96.0% | -20.5% |
Full HCA analysis · Full UNH analysis
HCA Healthcare (HCA) and UnitedHealth (UNH) on Torvanta's measures: HCA grades higher on 3 of the 4 factor families and UNH on 1. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings HCA trades at n/a and UNH at 25.8x; their value grades are B+ and B- against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer